Desloratadine
This medicine should always be taken exactly as described in this package leaflet or as directed by your doctor, pharmacist, or nurse.
Deslodyna fast junior, an orally disintegrating tablet, contains desloratadine, which is an antihistamine.
Deslodyna fast junior is an anti-allergic medicine that does not cause drowsiness. It helps control allergic reactions and their symptoms.
Deslodyna fast junior relieves symptoms associated with allergic rhinitis (inflammation of the nasal mucosa caused by an allergy, such as hay fever or allergy to dust mites) in adults, adolescents, and children aged 6 and older. Symptoms include: sneezing, runny or itchy nose, itchy palate, and itchy, red, or watery eyes. Deslodyna fast junior is also used to relieve symptoms associated with urticaria (a skin condition caused by an allergy). Symptoms of this condition include: itchy skin and urticaria. Relief of these symptoms persists throughout the day, making it easier to return to normal daily activities and normal sleep. If after 3 days there is no improvement or you feel worse, you should contact your doctor.
Before taking Deslodyna fast junior, you should discuss it with your doctor, pharmacist, or nurse:
This medicine should not be given to children under 6 years of age.
Tell your doctor or pharmacist about all medicines you are taking now or have recently taken, as well as any medicines you plan to take. No interactions with other medicines are known.
It is not necessary to take Deslodyna fast junior with water or any other liquid. Additionally, Deslodyna fast junior can be taken with or without food. Caution should be exercised when taking Deslodyna fast junior with alcohol.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a child, ask your doctor or pharmacist for advice before taking this medicine. It is not recommended to take Deslodyna fast junior during pregnancy or breastfeeding. Fertility: There are no available data on the effect on fertility in men and women.
It is unlikely that this medicine, when taken as recommended, will affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended to refrain from performing tasks that require concentration, such as driving or operating machinery, until you know how you react to this medicine.
The medicine contains 1.5 mg of aspartame in each orally disintegrating tablet. Aspartame is a source of phenylalanine. It may be harmful to patients with phenylketonuria. This is a rare genetic disorder in which phenylalanine accumulates in the body due to its improper excretion. The medicine contains 0.00281 mg of benzyl alcohol in each orally disintegrating tablet. Benzyl alcohol may cause allergic reactions. Pregnant or breastfeeding women should contact their doctor before taking the medicine, as a large amount of benzyl alcohol may accumulate in their body and cause side effects (so-called metabolic acidosis). Patients with liver or kidney disease should contact their doctor before taking the medicine, as a large amount of benzyl alcohol may accumulate in their body and cause side effects (so-called metabolic acidosis). The medicine contains less than 1 mmol (23 mg) of sodium in each orally disintegrating tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in this package leaflet or as directed by your doctor or pharmacist. If you are unsure, ask your doctor or pharmacist. The medicine is intended for oral use. Before taking, carefully open the blister by tearing it. Remove the orally disintegrating tablet without crushing it. Place it in your mouth, where it will immediately disintegrate. Water or any other liquid is not needed to swallow the dose. Take the dose immediately after opening the blister. Without consulting your doctor, do not take the medicine for more than 10 days. If after 3 days there is no improvement or you feel worse, you should contact your doctor.
The recommended dose is two tablets once a day, taken with or without food.
The recommended dose is one tablet once a day, taken with or without food.
Deslodyna fast junior should be taken only as described in this package leaflet or as directed by your doctor or pharmacist. In case of accidental overdose, severe disorders should not occur. However, if you take a higher dose of Deslodyna fast junior than recommended, you should immediately tell your doctor, pharmacist, or nurse.
If you miss a dose, take it as soon as possible, and then return to your regular dosing schedule. Do not take a double dose to make up for a missed dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist, or nurse.
Like all medicines, Deslodyna fast junior can cause side effects, although not everybody gets them. After the marketing of desloratadine, very rare cases of severe allergic reactions (difficulty breathing, wheezing, itching, urticaria, and swelling) have been reported. If you experience any of these severe side effects, you should stop taking the medicine and immediately see a doctor. In clinical trials in adult patients, side effects were almost the same as after taking a placebo. However, fatigue, dry mouth, and headache were reported more frequently than after taking a placebo. In adolescents, the most commonly reported side effect was headache. In clinical trials of desloratadine, the following side effects were reported:
After the marketing of desloratadine, the following side effects have been reported:
Frequency not known(frequency cannot be estimated from the available data):
Children
If you experience any side effects, including those not listed in this package leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety Monitoring of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl. Side effects can also be reported to the marketing authorization holder. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children. Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month stated. There are no special precautions for storage. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Deslodyna fast junior is a pink, orally disintegrating tablet with red-pink speckles, round, smooth, biconvex, with a beveled edge, without engraving, approximately 6 mm in diameter. One pack of the medicine contains 10 orally disintegrating tablets in OPA/Aluminum/PVC/Aluminum blisters in a cardboard box.
"PRZEDSIĘBIORSTWO PRODUKCJI FARMACEUTYCZNEJ HASCO-LEK" S.A., ul. Żmigrodzka 242 E, 51-131 Wrocław
tel.: (22) 742 00 22, email: informacjaoleku@hasco-lek.pl
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.